Literature DB >> 33346858

[Scabies-Renaissance of an ectoparasite infection : Diagnosis and therapy-How to proceed in practice].

Pietro Nenoff1, Anke Süß2, Ina Schulze3, Laura Meißner4, Christina Fritsch4, Bettina Schulz4, Silke Hennig4, Michael Borte4, Marlen Zurek4, Gabriele Ginter-Hanselmayer5.   

Abstract

Scabies or mange is currently a common dermatosis in Germany and other countries, and should be more important in health policy. It affects a cross-section of society, including all age groups, from infants to the aged. Locals and people with a migration background both suffer from this highly contagious ectoparasite infection with excessive, predominately nocturnal itching. Clinical diagnosis represents a challenge for the experienced dermatologist due to the variety of dermatosis to be considered in the differential diagnosis. It is still unclear whether treatment failure or the recurrences observed everywhere are due to in vitro and in vivo resistance of the pathogen agent Sarcoptes scabiei against permethrin or ivermectin. Therapeutic errors seem to play a role as often not all direct contact persons are recorded and treated with antiscabious treatment. They form the reservoir for reinfections. In the event of repeated nonresponse to topical (permethrin) and/or oral antiscabious treatment, alternative topical preparations-benzyl benzoate or crotamiton-should be used. Combination with ivermectin is mandatory.

Entities:  

Keywords:  Chronic recalcitrant course; Relapse; Resistance; Sarcoptes scabiei varietas hominis; Transmission

Mesh:

Substances:

Year:  2021        PMID: 33346858     DOI: 10.1007/s00105-020-04729-6

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  6 in total

1.  Gute Verträglichkeit und Wirkung der topischen Skabiestherapie mit Permethrin bei Kindern unter zwei Monaten.

Authors:  Johanna Charlotte Hoffmann; Rotraut Mößner; Michael Peter Schön; Undine Lippert
Journal:  J Dtsch Dermatol Ges       Date:  2019-06       Impact factor: 5.584

Review 2.  Zunahme von Skabies in Deutschland und Entwicklung resistenter Krätzemilben? Evidenz und Konsequenz.

Authors:  Cord Sunderkötter; Anton Aebischer; Matthias Neufeld; Christoph Löser; Alexander Kreuter; Ralf Bialek; Henning Hamm; Hermann Feldmeier
Journal:  J Dtsch Dermatol Ges       Date:  2019-01       Impact factor: 5.584

Review 3.  The Treatment of Scabies.

Authors:  Corinna Dressler; Stefanie Rosumeck; Cord Sunderkötter; Ricardo Niklas Werner; Alexander Nast
Journal:  Dtsch Arztebl Int       Date:  2016-11-14       Impact factor: 5.594

4.  Treatment of scabies with permethrin versus lindane and benzyl benzoate.

Authors:  U F Haustein; B Hlawa
Journal:  Acta Derm Venereol       Date:  1989       Impact factor: 4.437

Review 5.  Estimating the global burden of scabies: what else do we need?

Authors:  V Cox; L C Fuller; D Engelman; A Steer; R J Hay
Journal:  Br J Dermatol       Date:  2020-07-09       Impact factor: 9.302

Review 6.  Scabies: A comprehensive review and current perspectives.

Authors:  Pooja Arora; Lidia Rudnicka; Marta Sar-Pomian; Uwe Wollina; Mohammad Jafferany; Torello Lotti; Roxanna Sadoughifar; Zuzanna Sitkowska; Mohamad Goldust
Journal:  Dermatol Ther       Date:  2020-07-06       Impact factor: 2.851

  6 in total
  1 in total

Review 1.  Scabies: Epidemiology, Diagnosis, and Treatment.

Authors:  Cord Sunderkötter; Johannes Wohlrab; Henning Hamm
Journal:  Dtsch Arztebl Int       Date:  2021-10-15       Impact factor: 8.251

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.